Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Chest. 2011 Apr;139(4):855-861. doi: 10.1378/chest.10-1535. Epub 2010 Aug 19.
This study investigated poor prognostic factors in patients with stage IB non-small cell lung cancer (NSCLC) according to the seventh edition of the TNM classification.
Between July 1992 and December 2004, 1,204 consecutive patients with stage I NSCLC diagnosed based on the sixth edition TNM classification underwent complete resection with systematic node dissection. Of these patients, 434 were reclassified as stage IB according to the seventh edition TNM classification. Univariate analyses were performed using the log-rank test to select prognostic factors. The Cox proportional hazards regression model was used for multivariate analyses to identify independent factors indicating an unfavorable prognosis.
On multivariate analyses, two variables were independent significant factors indicating an unfavorable prognosis: presence of intratumoral vascular invasion and presence of visceral pleural invasion. According to subgroup analyses combining these two risk factors, 5-year disease-specific survival probabilities were 93%, 83%, and 73% for patients with zero, one, or two risk factors, respectively. The 5-year disease-specific survival of patients without risk factors was not statistically different from that of patients with stage IA cancer. In addition, the 5-year disease-specific survival curve of patients with two risk factors lay beneath that of patients with T2b or T3N0M0, stage II cancer, and there were no statistically significant differences between them.
We identified the presence of intratumoral vascular invasion and the presence of visceral pleural invasion as independent poor prognostic factors in patients with stage IB NSCLC. When these two factors are combined, higher- and lower-risk subgroups can be identified, which will help to personalize adjuvant chemotherapy.
本研究根据第七版 TNM 分类调查了 IB 期非小细胞肺癌(NSCLC)患者的预后不良因素。
1992 年 7 月至 2004 年 12 月,1204 例连续的 I 期 NSCLC 患者根据第六版 TNM 分类行完全切除术和系统性淋巴结清扫术。其中,434 例根据第七版 TNM 分类重新分类为 IB 期。使用对数秩检验对单变量分析进行了分析,以选择预后因素。Cox 比例风险回归模型用于多变量分析,以确定预示预后不良的独立因素。
多变量分析显示,两个变量是预示预后不良的独立显著因素:肿瘤内血管侵犯和脏层胸膜侵犯。根据结合这两个危险因素的亚组分析,5 年疾病特异性生存率分别为 93%、83%和 73%,分别为零、一个或两个危险因素的患者。无危险因素患者的 5 年疾病特异性生存率与 IA 期癌症患者无统计学差异。此外,具有两个危险因素的患者的 5 年疾病特异性生存曲线位于 T2b 或 T3N0M0、II 期癌症患者之下,且它们之间无统计学差异。
我们确定肿瘤内血管侵犯和脏层胸膜侵犯是 IB 期 NSCLC 患者的独立不良预后因素。当结合这两个因素时,可以确定更高和更低风险的亚组,这将有助于个体化辅助化疗。